---
title: Mr Arun Prasath Shanmugam
permalink: /arun-prasath-shanmugam/
variant: tiptap
description: ""
third_nav_title: Executive Committee
---
<p></p>
<div class="isomer-image-wrapper">
<img style="width: 50%;" height="auto" width="100%" alt="" src="/images/Leaders/EXCO 600x450/Arun_Prasath_Shanmugam.jpg">
</div>
<h5>Affiliations</h5>
<p>Platform Lead, Cancer Databases &amp; Tissue Banks, Singapore Translational
Cancer Consortium;</p>
<p></p>
<p>Director, Research Office, NUH Tissue Repository, National University
Health System (NUHS)</p>
<h5>Profile</h5>
<p><strong>Arun Prasath Shanmugam</strong> is a senior healthcare executive
with nearly two decades of experience in cellular therapy, biobanking,
and research operations. He currently serves as Director of the NUH Tissue
Repository, driving biobanking excellence, digitalisation, and automation
to support NUHS’s research and clinical missions.</p>
<p>Arun has a strong track record in organisational transformation, establishing
internationally accredited quality systems, and delivering enterprise-scale
transformation. Prior to his current role, he was Director of the Singapore
Cord Blood Bank (SCBB), where he led strategic initiatives to enhance business
operations, quality management, and regulatory compliance. Under his leadership,
SCBB achieved four international accreditations (AABB, FACT, CAP, WMDA),
placing it among the most comprehensively accredited banks globally.</p>
<p>Beyond his organisational roles, Arun contributes extensively to the global
cellular therapy and stem cell banking community. He serves as an Accreditation
Assessor for the Association for the Advancement of Blood &amp; Biotherapies
(AABB) and an Inspector for the Foundation for the Accreditation of Cellular
Therapy (FACT). He is also an active member of multiple committees under
World Marrow Donor Association (WMDA), shaping standards and best practices
for hematopoietic stem cell transplantation and cellular therapy.</p>
<p>His research contributions span stem cell transplantation, cord blood
banking, and cellular therapy, with publications in leading journals.</p>
<h5>Selected Publications</h5>
<p>&nbsp;Wong CM, Tan CS, Riard N, Padmini YS, Daniel LM, Prasath A, Tan
AM, Tan TC, Sultana R, Lam JCM. Autologous umbilical cord blood infusion
for the treatment of autism in young children: A within-subjects open label
study on safety (assessed via caregiver report) and efficacy. Autism Res.
2024 Aug;17(8):1721-1734.</p>
<p>Wong J, Govindasamy G, Prasath A, Hwang W, Ho A, Yeo S, Tong L. Allogeneic
Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye
Disease Patients. Journal of Clinical Medicine. 2023;12(21):6750.</p>
<p>Ng AY-J, Moshi GB, Arun Prasath, Chan M, Michelle PL, Loh CKC, Cho L,
Voon V, Jing SZ, Yen PC, Ho AYL. Human leukocyte antigen allele and haplotype
frequencies in Singapore bone marrow donors and cord blood units. Blood
Cell Therapy. 2022;5(4):99-106.</p>
<p>Trépanier P, Fournier D, Simard C, Fontaine MJ, Stroncek D, Takanashi
M, McKenna D, Schwartz J, Tanhehco YC, Reems JA, Torrents S, Kogler G,
Liedtke S, Giroux M, Holovati JL, Louis I, Prasath A, Pineault N, Bazin
R; BEST Collaborative. Multicenter evaluation of the IL-3-pSTAT5 assay
to assess the potency of cryopreserved stem cells from cord blood units.
Transfusion. 2022 Jun 30.&nbsp;</p>
<p>Prasath A, Ho A, Ng J, Lin PY, Yang KL. Discovery of a novel HLA-A*02
variant, HLA-A*02:402, in a Singaporean cord blood unit. HLA. 2020 Aug;96(2):205-206.</p>
<p>Fournier D, Lewin A, Simard C, Trépanier P, Néron S, Ballerini L, Codinach
M, Elmoazzen H, Halpenny M, Kogler G, Liedtke S, Louis I, Molluna CA, Pineault
N, Prasath A, Querol S, Saccardi R, Sutherland DR, Thérien C, Urbani S.
Multi-laboratory assay for harmonization of enumeration of viable CD34+
and CD45+ cells in frozen cord blood units. Cytotherapy. 2020;22(1):44-51.&nbsp;</p>
<p>Chu PPY, Arun Prasath, Li Z, Bari S, Ang JML, Fan X, Zhang C, Lodish HF,
Hwang WYK. Mesenchymal Stromal Cell Co-Culture Enhances IGFBP2-augmented
ex vivo cultures of human cord blood via viability-supporting, contact-dependent
rescue from early apoptosis. Blood. 2008;112(11):211.</p>
<p>Feng Q, Chow PK, Frassoni F, Phua CM, Tan PK, Prasath A, Khee Hwang WY.
Nonhuman primate allogeneic hematopoietic stem cell transplantation by
intraosseous vs intravenous injection: Engraftment, donor cell distribution,
and mechanistic basis. Exp Hematol. 2008;36(11):1556-66.</p>
<p></p>